Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127228861 | 12722886 | 1 | I | 20160905 | 20160907 | 20160907 | EXP | JP-ROCHE-1825577 | ROCHE | SUZUKI S, SHIMAZAKI J, MORISHITA K, KOIKE N, HARADA N, HAYASHI T AND SUZUKI M EFFICACY AND SAFETY OF OXALIPLATIN, BEVACIZUMAB AND ORAL S-1 FOR ADVANCED RECURRENT COLORECTAL CANCER. MOLECULAR AND CLINICAL ONCOLOGY 2016;5 (4):391-394. | 0.00 | Y | 0.00000 | 20160908 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127228861 | 12722886 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | ON DAY 1 | U | 125085 | 5 | MG/KG | SOLUTION FOR INFUSION | ||||||
| 127228861 | 12722886 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | ON DAYS 1 TO 14 | U | 0 | 85 | MG/M**2 | |||||||
| 127228861 | 12722886 | 3 | SS | TS-1 | GIMERACILOTERACILTEGAFUR | 1 | Oral | ON DAY 1-14 | U | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127228861 | 12722886 | 1 | Colorectal cancer |
| 127228861 | 12722886 | 2 | Colorectal cancer |
| 127228861 | 12722886 | 3 | Colorectal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127228861 | 12722886 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127228861 | 12722886 | Alanine aminotransferase increased | |
| 127228861 | 12722886 | Alopecia | |
| 127228861 | 12722886 | Anaemia | |
| 127228861 | 12722886 | Aspartate aminotransferase increased | |
| 127228861 | 12722886 | Blood pressure increased | |
| 127228861 | 12722886 | Decreased appetite | |
| 127228861 | 12722886 | Diarrhoea | |
| 127228861 | 12722886 | Leukopenia | |
| 127228861 | 12722886 | Nausea | |
| 127228861 | 12722886 | Peripheral sensory neuropathy | |
| 127228861 | 12722886 | Rash | |
| 127228861 | 12722886 | Stomatitis | |
| 127228861 | 12722886 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |